Los Angeles Capital Management LLC Vanda Pharmaceuticals Inc. Transaction History
Los Angeles Capital Management LLC
- $22.3 Billion
- Q1 2025
A detailed history of Los Angeles Capital Management LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 37,931 shares of VNDA stock, worth $163,861. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,931
Previous 232,081
83.66%
Holding current value
$163,861
Previous $1.11 Million
84.34%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding VNDA
# of Institutions
158Shares Held
44.7MCall Options Held
64.8KPut Options Held
562K-
Black Rock Inc. New York, NY8.14MShares$35.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.57MShares$15.4 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.5MShares$15.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$11 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.2 Million0.7% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $244M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...